0001415889-18-001318.txt : 20180831
0001415889-18-001318.hdr.sgml : 20180831
20180831172447
ACCESSION NUMBER: 0001415889-18-001318
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180829
FILED AS OF DATE: 20180831
DATE AS OF CHANGE: 20180831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIN JERRY B
CENTRAL INDEX KEY: 0000901014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 181050765
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-08312018_020832.xml
X0306
4
2018-08-29
0001411685
VistaGen Therapeutics, Inc.
VTGN
0000901014
GIN JERRY B
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Stock Option (Right to Buy)
8
2018-08-29
4
D
0
25000
0
D
2017-03-30
2026-03-30
Common Stock
25000
0
D
Stock Option (Right to Buy)
1.50
2018-08-29
4
A
0
25000
0
A
2018-08-29
2026-03-30
Common Stock
25000
25000
D
Stock Option (Right to Buy)
3.49
2018-08-29
4
D
0
25000
0
D
2026-06-19
Common Stock
25000
0
D
Stock Option (Right to Buy)
1.50
2018-08-29
4
A
0
25000
0
A
2026-06-19
Common Stock
25000
25000
D
Stock Option (Right to Buy)
3.80
2018-08-29
4
D
0
25000
0
D
2026-11-09
Common Stock
25000
0
D
Stock Option (Right to Buy)
1.50
2018-08-29
4
A
0
25000
0
A
2026-11-09
Common Stock
25000
25000
D
Stock Option (Right to Buy)
1.96
2018-08-29
4
D
0
35000
0
D
2026-11-09
Common Stock
35000
0
D
Stock Option (Right to Buy)
1.50
2018-08-29
4
A
0
35000
0
A
2026-11-09
Common Stock
35000
35000
D
The reporting person agreed to cancellation of an option granted to him on 3/30/2016 in exchange for a new option having a lower exercise price.
The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price.
The option vests monthly over a period of four years commencing 6/19/2016.
The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price.
The option vests monthly over a period of three years commencing 11/9/2016.
The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price.
The option vests monthly over a period of three years commencing 4/26/2017.
/s/ Jerrold D. Dotson, Attorney-in-Fact
2018-08-31